Asset Details
Do you wish to reserve the book?
The adipokine fatty-acid binding protein 4 and cardiac remodeling
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The adipokine fatty-acid binding protein 4 and cardiac remodeling
Do you wish to request the book?
The adipokine fatty-acid binding protein 4 and cardiac remodeling
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The adipokine fatty-acid binding protein 4 and cardiac remodeling
2020
Overview
Background
Previous publications about the association between fatty-acid binding protein 4 (FABP4) and cardiac remodeling have reported different, both beneficial and harmful, associations. Aim of the present investigation was to evaluate the association of FABP4 with parameters of myocardial remodeling defined by cardiac magnetic resonance imaging (CMR).
Methods
We investigated plasma FABP4 levels in 331 patients (71% men, mean age 63±13 years) with preserved left ventricular ejection fraction (LVEF ≥ 55%) who underwent a CMR examination. We used linear cox regression to investigate associations between FABP4 and left ventricular end-diastolic diameter (LVEDD), right ventricular end-diastolic diameter (RVEDD), relative wall thickness (RWT), left ventricular mass index (LVMI), and LVEF (unadjusted and adjusted for age, sex, body mass index, cardiac biomarkers, and comorbidities).
Results
FABP4 levels were associated with lower LVMI and higher NT-proBNP levels in an adjusted model. The inverse association between FABP4 and LVMI was more pronounced in lower FABP4 levels, whereas the positive association between FABP4 and NT-proBNP was more pronounced in relatively high NT-proBNP levels.
Conclusions
Possible beneficial and harmful associations between FABP4 and left ventricular size have been reported. Our results suggest a beneficial association with LVMI (more pronounced in lower FABP4 levels) but a harmful association with NT-proBNP (more pronounced in higher FABP4 levels). Therefore, our results might indicate a potential dose-dependent association of FABP4, but this observation needs further investigation in larger study samples.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
/ Aged
/ Cardiac magnet resonance imaging, CMR
/ Diabetes
/ Fatty Acid-Binding Proteins - blood
/ Fatty-acid binding protein 4 (FABP4)
/ Female
/ Heart
/ Humans
/ Hypertrophy, Left Ventricular - blood
/ Hypertrophy, Left Ventricular - diagnostic imaging
/ Hypertrophy, Left Ventricular - physiopathology
/ Left-ventricular hypertrophy
/ Male
/ Medicine
/ Natriuretic Peptide, Brain - blood
/ Obesity
/ Studies
We currently cannot retrieve any items related to this title. Kindly check back at a later time.